Project Details
Description
A Pilot Phase II Double-Blind, Placebo-Controlled, Dosage Finding and Tolerability Study of Isradipine as a Disease Modifying Agent in Patients with Early Parkinson's Disease
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/09 → 7/31/12 |
Funding
- NORTHWESTERN UNIVERSITY
- MICHAEL J. FOX FDN FOR PARKINSON'S RES.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.